

Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














	Donald J Zurbay Joins Avedros Board Of Directors













































Employer:
Login
Post Jobs


Job Seeker:
Login
Sign Up

























Search Life Sciences Jobs





Search Job Title Only












Radius:
Miles



Km80.5
















                 News | News By Subject | News by Disease |  
    News By Date | Search News



















Get Our FREEIndustry eNewsletter

email:


*
            
*
            



















 

 






Donald J. Zurbay Joins Avedro’s Board Of Directors  











Tweet








7/18/2017 6:53:03 AM




  Life Sciences Jobs
 


  &bullet; Newest Jobs - Last 24 Hours


  &bullet; California Jobs


  &bullet; Massachusetts Jobs


  &bullet; New Jersey Jobs


  &bullet; Maryland Jobs


  &bullet; Washington Jobs


  View More Jobs



WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc., an ophthalmic pharmaceutical and medical device company 
      and the world leader in corneal remodeling, today announced that Donald 
      J. Zurbay has been elected to its board of directors.
    
“I’m thrilled to be joining Avedro’s board of directors and look forward 
      to contributing to the business as they continue to execute their plans 
      in expanding both in the US and internationally”

      A veteran finance executive with more than 27 years in financial 
      operations and accounting, Mr. Zurbay is the former vice president and 
      chief financial officer (CFO) of St. Jude Medical, Inc., a Fortune 500 
      multi-national medical device company. During his tenure at St. Jude 
      Medical, Mr. Zurbay helped guide the company through significant growth 
      and expansion, including nineteen acquisitions, and ultimately the 
      recent transaction to sell St. Jude Medical to Abbott for $25 billion.
    

      “Don is an accomplished business leader with a proven track record of 
      developing strategy and driving execution for business growth. He will 
      be a superb advisor to Avedro and we are pleased to welcome him to the 
      Board,” said Reza Zadno, Ph.D., chief executive officer of Avedro. 
      “Don’s guidance will be indispensable as we continue to expand our 
      ability to deliver innovative products that dramatically improve the 
      lives of patients with keratoconus and develop new and innovative 
      cross-linking applications that help reduce the need for eyeglasses and 
      contact lenses.”
    

      “I’m thrilled to be joining Avedro’s board of directors and look forward 
      to contributing to the business as they continue to execute their plans 
      in expanding both in the US and internationally,” said Mr. Zurbay.
    

About Avedro, Inc.Avedro is a privately held pharmaceutical 
      and medical device company and the world leader in corneal remodeling. 
      Avedro’s patented cross-linking technology, consisting of drug 
      formulations and medical devices, are approved for sale in numerous 
      countries around the globe. In the United States the company sells an 
      orphan drug, indicated for the treatment of progressive keratoconus, 
      which was FDA approved in 2016. Avedro continues to develop proprietary 
      cornea cross-linking products for the treatment of keratoconus, a 
      sight-threatening disease, and for refractive correction.
    








Contacts


Avedro Contact:Avedro, Inc.David Iannetta, 
      781-768-3400info@avedro.comorMedia 
      Contact:BioComm Network, Inc.Michele Gray, 917-449-9250michele_gray@me.com








                Read at
                BioSpace.com







Related News
Massachusetts' Avedro Banks $42 Million, Opens New Facility and Will Continue to Expand Its Team  Debt-Ridden Valeant (VRX) Dumps Another Asset in $190 Million Cash Deal  Avedro Names Thomas E. Griffin Chief Financial Officer  Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA Avedro Release: First FDA Approved Cross-Linking Procedures Are Performed On Patients In The U.S. With Progressive Keratoconus  GlaxoSmithKline (GSK) Poaches Another Top Exec—This Time From Pfizer (PFE)  Avedro Release: Two Studies Demonstrate Promising Results Of PiXL Procedure (Photorefractive Intrastromal Corneal Collagen Cross-Linking) For Non-Invasive Treatment Of Low Myopia  'Retired' Celgene (CELG) Alum Lands Chairman Gig at Biotech Guru Ramaswamy's Dermavant Avedro Receives Additional Indication For Photrexa Viscous, Photrexa And The KXL System For The Treatment Of Corneal Ectasia Following Refractive Surgery  Backed by Google (GOOG), Evelo Bags $50 Million and Names Some Industry Vets to the Team  




Please enable JavaScript to view the comments powered by Disqus.
comments powered by Disqus






















                            •
                            BioSpace.com










                            •
                            Avedro, Inc.




             
        





                            •
                            Biotech/Pharma - Personnel



                            •
                            Medical Devices



                            •
                            Medical Dev. & Diag. - Personnel




             
        















                              
                            

                              
                             
                              
                            

                              
                            








                 































Executive Profile | St. Jude Medical, Inc. | Donald J. Zurbay | Customer Intelligence

































































                    Home
                  



					About Us	
                  



					Pricing	
                  



					Contact	
                  



					Resources	
                  



					Blog	
                  



Log In















 











Donald J. Zurbay 

		
		VP, Finance and CFO, 

	
		 St. Jude Medical, Inc. 	

 
Last Updated: 10/19/2016 



Executive Summary
Experience financial executive Donald Zurbay joined St. Jude Medical in 2003 as the Director of Finance.  A year later he was named the Company’s Corporate Controller, and was promoted to his current role of Chief Financial Officer in 2012.  Zurbay is responsible for finance, investor relations and the Company’s i 
Current Focus

Sale of vascular closure and electrophysiology businesses: In October 2016, St. Jude Medical and Abbott Laboratories said they would sell certain businesses to Japanese medical-equipment maker Terumo Corp. for about $1. 
Key Challenges

Product delays: In an April 2016 earnings call, Zurbay said he was “pleased with the momentum” of the majority of St. Jude’s businesses, but he noted that traditional CRM sales continue to slow, due in 
Biographical Highlights

Born c. 1967
Zurbay holds a BS in business with an emphasis in accounting from the University of Minnesota. 
Other Boards and Organizations

Former Member, Board of Directors, Advanced Neuromodulation Systems Inc.
Former Member, Board of Directors, AGA Medical Holdings, Inc. 
 





These companies are using Boardroom Insiders to close bigger deals, faster:























View Full Samples Now!














			WATCH OUR VIDEO
			



















© 2017 Boardroom Insiders, Inc. All rights reserved. 
All trademarks are the property of their respective owners.


Privacy Policy
Contact Us
















 



Donald J. Zurbay Joins Avedro’s Board of Directors | Business Wire
























































Donald J. Zurbay Joins Avedro’s Board of Directors






July 18, 2017 08:30 AM Eastern Daylight Time



WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc., an ophthalmic pharmaceutical and medical device company 
      and the world leader in corneal remodeling, today announced that Donald 
      J. Zurbay has been elected to its board of directors.
    


      A veteran finance executive with more than 27 years in financial 
      operations and accounting, Mr. Zurbay is the former vice president and 
      chief financial officer (CFO) of St. Jude Medical, Inc., a Fortune 500 
      multi-national medical device company. During his tenure at St. Jude 
      Medical, Mr. Zurbay helped guide the company through significant growth 
      and expansion, including nineteen acquisitions, and ultimately the 
      recent transaction to sell St. Jude Medical to Abbott for $25 billion.
    

      “Don is an accomplished business leader with a proven track record of 
      developing strategy and driving execution for business growth. He will 
      be a superb advisor to Avedro and we are pleased to welcome him to the 
      Board,” said Reza Zadno, Ph.D., chief executive officer of Avedro. 
      “Don’s guidance will be indispensable as we continue to expand our 
      ability to deliver innovative products that dramatically improve the 
      lives of patients with keratoconus and develop new and innovative 
      cross-linking applications that help reduce the need for eyeglasses and 
      contact lenses.”
    

      “I’m thrilled to be joining Avedro’s board of directors and look forward 
      to contributing to the business as they continue to execute their plans 
      in expanding both in the US and internationally,” said Mr. Zurbay.
    

About Avedro, Inc.Avedro is a privately held pharmaceutical 
      and medical device company and the world leader in corneal remodeling. 
      Avedro’s patented cross-linking technology, consisting of drug 
      formulations and medical devices, are approved for sale in numerous 
      countries around the globe. In the United States the company sells an 
      orphan drug, indicated for the treatment of progressive keratoconus, 
      which was FDA approved in 2016. Avedro continues to develop proprietary 
      cornea cross-linking products for the treatment of keratoconus, a 
      sight-threatening disease, and for refractive correction.
    




Contacts

Avedro Contact:Avedro, Inc.David Iannetta, 
      781-768-3400info@avedro.comorMedia 
      Contact:BioComm Network, Inc.Michele Gray, 917-449-9250michele_gray@me.com














Release Summary
Avedro, the world leader in corneal remodeling, announced that Donald J. Zurbay joined its board of directors.







Contacts

Avedro Contact:Avedro, Inc.David Iannetta, 
      781-768-3400info@avedro.comorMedia 
      Contact:BioComm Network, Inc.Michele Gray, 917-449-9250michele_gray@me.com







 
 

 






Search




Advanced News Search

Advanced News Search













Log In
Sign Up












﻿

Company Profile








































 











 Add Company


Sign in with 
Sign in with 




















Add Company


Add Event


Sign in with 


Sign in with 


Android


iPhone









Companies
Events



 Company
 Events






















Message this company



Message the business




































Message this company


Message the business 













 Post your social media updates






































Network























































































Would you like BusinessVibes to send this message to similar companies in this industry?















Profile Visits

Prev. Visits :
Total :
Current :







Share and improve this company’s performance.
Boost this company’s visibility by sharing it with your contacts






About Company
Financial Details













 























































































































X

Receive updates from "Textiles" companies in "India" for free

Receive updates from "Textiles" companies in "India" for free










*



*











Already a BusinessVibes member? Login




What kind of updates will I receive?
 Latest business listings as they become available
 Current trends that are making noise in your industry
 Reports and articles about your market pushed directly to you
 You will also receive early access to the BusinessVibes mobile app


Access to full profiles can help you
 Instantly contact businesses directly
 Pursue and qualify leads for your business
 Research and find business offerings that you seek
 You will also receive early access to the BusinessVibes mobile app








X

We're glad that you're back. Simply Login and unlock full profile



Easy one click Login Don't worry, we never post without your permission.


- - - - - - - - Or - - - - - - - -
Already an active user? Login with your email



*



*
Forgot password?




New to BusinessVibes? Sign up






X


Receive updates from "Textiles" companies in "India" for free




























Already in BusinessVibes? Login




Access to open trade requests can help you
 Find products and services early
 Less Competition for trade requests
 More cost-effective than traditional trade requests







 














 



Donald J. Zurbay Joins Avedros Board of Directors




















HomeGo

NewsLocal NewsInvestigations5 On Your SideImmigration/Border WallPhotographer's PerspectiveHeart of the ValleyFind The LinkSubmit a TipPump PatrolNews StaffInvestigationsWeatherHourly ForecastLatest WeathercastInteractive RadarTraffic MapWindsTide InformationLake LevelsHurricane CentralWeather RadioWeather LinksSend A Weather QuestionWeather TeamSportsSend a Sports TipSports StaffProgrammingTV ListingsMastermindsAntennasLitton's Weekend AdventureRatings GuideInside The ValleyMeTVThis TVSAP InformationCommunityCommunity NewsCon Mi GenteEducation BeatHeart of the ValleyInside The ValleyTeach The Children5's Fans for FriendsTim's CoatsCommunity CalendarZoo GuestPet Of The WeekMastermindsBreaking the BarriersConnectJobs at KRGVContact UsNews StaffSales StaffApps & Social MediaStation InformationRequest for PSARequest for Talent AppearanceLocal Business HappeningsAdvertising InformationFCC ReportsSAP InformationFrequently Asked QuestionsEspañolNoticiasComunidadClimaCorazón del ValleVideos En Español¿Qué es SAP?Submit a Tip







Donald J. Zurbay Joins Avedros Board of Directors
Posted: 

Tuesday, July 18, 2017 8:47 AM EDT
Updated: 

Tuesday, July 18, 2017 8:47 AM EDT





WALTHAM, Mass. --(BUSINESS WIRE)       Avedro, Inc., an ophthalmic pharmaceutical and medical device company       and the world leader in corneal remodeling, today announced that Donald       J. Zurbay has been elected to its board of directors.          A veteran finance executive with more than 27 years in financial       operations and accounting, Mr. Zurbay is the former vice president and       chief financial officer (CFO) of St. Jude Medical, Inc., a Fortune 500       multi-national medical device company. During his tenure at St. Jude       Medical, Mr. Zurbay helped guide the company through significant growth       and expansion, including nineteen acquisitions, and ultimately the       recent transaction to sell St. Jude Medical to Abbott for $25 billion.          “Don is an accomplished business leader with a proven track record of       developing strategy and driving execution for business growth. He will       be a superb advisor to Avedro and we are pleased to welcome him to the       Board,” said Reza Zadno, Ph.D., chief executive officer of Avedro.       “Don’s guidance will be indispensable as we continue to expand our       ability to deliver innovative products that dramatically improve the       lives of patients with keratoconus and develop new and innovative       cross-linking applications that help reduce the need for eyeglasses and       contact lenses.”          “I’m thrilled to be joining Avedro’s board of directors and look forward       to contributing to the business as they continue to execute their plans       in expanding both in the US and internationally,” said Mr. Zurbay.    About Avedro, Inc.Avedro is a privately held pharmaceutical       and medical device company and the world leader in corneal remodeling.       Avedro’s patented cross-linking technology, consisting of drug       formulations and medical devices, are approved for sale in numerous       countries around the globe. In the United States the company sells an       orphan drug, indicated for the treatment of progressive keratoconus,       which was FDA approved in 2016. Avedro continues to develop proprietary       cornea cross-linking products for the treatment of keratoconus, a       sight-threatening disease, and for refractive correction.    View source version on businesswire.com: http://www.businesswire.com/news/home/20170718005217/en/Avedro Contact:Avedro, Inc.David Iannetta,       781-768-3400info@avedro.comorMedia       Contact:BioComm Network, Inc.Michele Gray, 917-449-9250michele_gray@me.comCopyright Business Wire 2017Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and have questions or removal reuqests please contact pressreleases@franklyinc.com
















CURRENT CONDITIONS / 7-day ForecastLatest WeathercastHourly ForecastTexas Radar









Eyewire Today | Donald J. Zurbay Joins Avedro’s Board of Directors















































Home
EyewireTV
News
Events
Login












Username:

Password:



























Home
EyewireTV
News
Events


















Donald J. Zurbay Joins Avedro’s Board of Directors


Source: Avedro
Tuesday, July 18, 2017 | 
						Management/Leadership
						,
						Avedro








Avedro announced that Donald J. Zurbay has been elected to its board of directors. A veteran finance executive with more than 27 years in financial operations and accounting, Mr. Zurbay is the former vice president and chief financial officer (CFO) of St. Jude Medical, a Fortune 500 multi-national medical device company. During his tenure at St. Jude Medical, Mr. Zurbay helped guide the company through significant growth and expansion, including 19 acquisitions, and ultimately, the recent transaction to sell St. Jude Medical to Abbott for $25 billion.
“Don is an accomplished business leader with a proven track record of developing strategy and driving execution for business growth. He will be a superb advisor to Avedro and we are pleased to welcome him to the Board,” Reza Zadno, PhD, chief executive officer of Avedro, said in a company news release. “Don’s guidance will be indispensable as we continue to expand our ability to deliver innovative products that dramatically improve the lives of patients with keratoconus and develop new and innovative cross-linking applications that help reduce the need for eyeglasses and contact lenses.”
“I’m thrilled to be joining Avedro’s board of directors and look forward to contributing to the business as they continue to execute their plans in expanding both in the US and internationally,” said Mr. Zurbay.

Comments
You must be logged in to leave a comment.












Upcoming Events




					8/10/2017: OIS@ASRS




					8/11/2017: American Society of Retina Specialists Meeting





Featured Stories


Thursday, July 27, 2017 |
					
					FDA Approval/Clearance,
					Product Releases,
					Quantel Medical
Quantel Medical Receives FDA Approval for Easyret Photocoagulator Laser

Quantel Medical announced that it has received approval from the FDA for the Easyret fully integrated 577nm yellow photocoagulator, which is used to t…
Read the full story




Wednesday, July 26, 2017 |
					
					Clinical Trials,
					Earnings & Financials,
					AMD,
					Ophthotech
Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases
Ophthotech announced that the company is pursuing a strategy to leverage its clinical experience and retina expertise to identify and develop therapie…
Read the full story




Monday, July 24, 2017 |
					
					Product Releases
Cenegermin Eye Drops For the Treatment of Neurotrophic Keratitis Receive European Union Approval
Dompe announced that the European Commission has granted the marketing authorization of cenegermin eye drops for the treatment of moderate to severe n…
Read the full story




Friday, July 21, 2017 |
					
					Dry Eye,
					Medical Studies
TFOS DEWS II Report Published; Dry Eye Disease Redefined 

The long-awaited Tear Film & Ocular Surface Society (TFOS) Dry Eye Workshop II (DEWS II) report was published on July 21, 2017, updating the defin…
Read the full story




Tuesday, July 18, 2017 |
					
					Earnings & Financials,
					Alcon
Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe…
Read the full story



















News
Company News
Product News
Research
Meetings
 
Events
EyewireTV
Login




Acquisitions
Blindness
Clinical Trials
Conferences/Meetings
Lawsuits
Earnings & Financials
FDA Approval/Clearance
Glaucoma
Health Care




International Approvals
Management/Leadership
Medical Studies
Miscellaneous
Optometry
Partnerships
Practice Development
Product Releases
Retina




Contact
Advertising
About
Send a tip or event
 



© 2017 Bryn Mawr Communications, LLC.All Rights Reserved














Donald J. Zurbay Joins Avedro’s Board of Directors | FinancialContent Business Page 















Home
Products & Services
Support
About
Contact Us




Online Services
Financial Widgets
Financial Pages
Web Services
Consulting
Desktop Services
Financial Calculations
Stock Data for Excel
Newspaper Services


Advertising Services
For Advertisers
Advertise on our Network
Sites & Reach
For Publishers
Monetization Services
Distribution Services
Content Syndication
Press Release Distribution
News and Blog Syndication
Data Syndication


For Developers
Web Developers
Social App Developers
AJAX Developers
Software Developers
Mobile App Developers
Financial Databases


By Industry
Online Media
Financial Services
Newspaper
Investor Relations
Magazine
Television
Wireless
Wire Services
Radio




Contact Us
Open a Trouble Ticket

Phone:  (888) 688-9880
Documentation
Advertising Formats
Stock Chart API
Fundamental Data
Symbol Map API
Snapshot Quotes


Articles
Adding stock quotes to your website
How to set up your white-labelled stock quote pages
Instructions for setting up DNS/URL masking
Tagging ticker symbols within your stories and in your RSS feed
Integrating Modules and Widgets
Billing Information
Billing Information
Payment Options




About Us
Overview
Management Team
Careers
Partners
Data Partners
Technology Partners
Wire Services


Monthly Newsletter
April 2012 - Setting Up HTML Wrapper for Finance Channel
March 2012 - Stock Quotes for Excel and Most Searched Stocks
February 2012 - Web Services, APIs, Financial Pages and Monetization
View Archive
In the news
11/22/2011: TalkingBizNews - Economy Widget feature
10/27/2011: Top Business and Financial Vertical Ad Networks







	FinancialContent is the trusted provider of stock market information to the media industry.












Markets
Stocks
Funds
Sectors
Tools


Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds




Search InvestCenter



Recent Quotes

View Full List



My Watchlist

Create Watchlist



Indicators

Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil






















  By:
  Avedro, Inc. via 
  Business Wire News Releases

July 18, 2017 at 08:30 AM EDT

Donald J. Zurbay Joins Avedro’s Board of Directors


  Avedro, the world leader in corneal remodeling, announced that Donald J. Zurbay joined its board of directors.
 



      Avedro, Inc., an ophthalmic pharmaceutical and medical device company 
      and the world leader in corneal remodeling, today announced that Donald 
      J. Zurbay has been elected to its board of directors.
    
      A veteran finance executive with more than 27 years in financial 
      operations and accounting, Mr. Zurbay is the former vice president and 
      chief financial officer (CFO) of St. Jude Medical, Inc., a Fortune 500 
      multi-national medical device company. During his tenure at St. Jude 
      Medical, Mr. Zurbay helped guide the company through significant growth 
      and expansion, including nineteen acquisitions, and ultimately the 
      recent transaction to sell St. Jude Medical to Abbott for $25 billion.
    




      “Don is an accomplished business leader with a proven track record of 
      developing strategy and driving execution for business growth. He will 
      be a superb advisor to Avedro and we are pleased to welcome him to the 
      Board,” said Reza Zadno, Ph.D., chief executive officer of Avedro. 
      “Don’s guidance will be indispensable as we continue to expand our 
      ability to deliver innovative products that dramatically improve the 
      lives of patients with keratoconus and develop new and innovative 
      cross-linking applications that help reduce the need for eyeglasses and 
      contact lenses.”
    
      “I’m thrilled to be joining Avedro’s board of directors and look forward 
      to contributing to the business as they continue to execute their plans 
      in expanding both in the US and internationally,” said Mr. Zurbay.
    About Avedro, Inc.Avedro is a privately held pharmaceutical 
      and medical device company and the world leader in corneal remodeling. 
      Avedro’s patented cross-linking technology, consisting of drug 
      formulations and medical devices, are approved for sale in numerous 
      countries around the globe. In the United States the company sells an 
      orphan drug, indicated for the treatment of progressive keratoconus, 
      which was FDA approved in 2016. Avedro continues to develop proprietary 
      cornea cross-linking products for the treatment of keratoconus, a 
      sight-threatening disease, and for refractive correction.
    View source version on businesswire.com: http://www.businesswire.com/news/home/20170718005217/en/ 








  Contacts: 
Avedro Contact:Avedro, Inc.David Iannetta, 
      781-768-3400info@avedro.comorMedia 
      Contact:BioComm Network, Inc.Michele Gray, 917-449-9250michele_gray@me.com






















Stock Market JSON API provided by www.cloudquote.net
  Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. 
  By accessing this page, you agree to the following
Privacy Policy and 
  Terms and Conditions.
Press Release Service provided by PRConnect.
  
  Stock quotes supplied by Six Financial
 




































		 
		
		 
	












Financial Widgets
Display market data, financial news or stock quotes - Learn More


Advertising Network
Advertise on FinancialContent's huge network - Learn More


Web Services
Power your internet and wireless applications - Learn More









© Copyright  FinancialContent Services, Inc.
Terms and Conditions
Privacy Policy
Contact Us






Contact Us
(888) 688-9880



Services
Financial Widgets
Financial Pages
Web Services
Consulting
Financial Calculations
Stock Data for Excel
Newspaper Services
For Advertisers
Monetization Services
Content Syndication
Press Release Syndication


Services by Industry
Online Media
Financial Services
Newspaper
Investor Relations
Financial Blog
Corporate Intranets
Digital Signage
Television
Android Developers
iOS Developers
Wire Services
Radio


About Us
Overview
Careers
Management Team
Latest News
Newsletters


Support
Support Articles

Report an issue






